Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
NUZ Announcements
HEALEY ALS Trial Regimen I Expands to…
NUZ
NEURIZON THERAPEUTICS LIMITED
Market sensitive
HEALEY ALS Trial Regimen I Expands to 240 Participants
Date and time
27 May 2026 at 7:20 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
NUZ announcement history
Recent NUZ announcements
Elanco representative appointed as Neurizon Board Observer
Neurizon Completes Initial Drawdown under R&D Facility
Appendix 4C & Quarterly Update
Neurizon Enters Strategic R&D Financing Facility
Melbourne investor briefing presentation
HEALEY Enrolment Complete - Topline Accelerated to Q2 CY27